An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A (Q63571464)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A |
clinical trial |
Statements
A Phase III Open Label, Multicenter, Extension Study to Assess the Safety and Efficacy of Recombinant Coagulation Factor VIII (rVIII‑SingleChain, CSL627) in Subjects With Severe Hemophilia A (English)
0 references
13 October 2014
0 references
27 August 2021
0 references
250
0 references